Number of Shares
1.72 Mil
Current Holdings Value*
$20.11 Mil
% of Portfolio
3.59%
Total Estimate Gain
$-150,430.98
% of Total Estimate Gain
-0.41%

SAMSARA BIOCAPITAL, LLC's Neurogene Inc Holding Summary

As of 2025-03-31, SAMSARA BIOCAPITAL, LLC held 1.72 Mil shares of Neurogene Inc(NGNE), totaling $20.11 Mil. This investment constitutes 3.59% of their stock portfolio, and SAMSARA BIOCAPITAL, LLC now holds 12.04% of the outstanding Neurogene Inc(NGNE) stock.

The initial trade took place in 2023Q4. And since then SAMSARA BIOCAPITAL, LLC has made 2 purchases of NGNE, at an average price of $21.52, for a total of 1.72 Mil shares. Based on historical transaction data and NGNE's current price of $21.43, SAMSARA BIOCAPITAL, LLC's estimated gain on his NGNE holdings is $-150,430.98, reflecting a -0.41% gain to date.

SAMSARA BIOCAPITAL, LLC NGNE ($21.43) Holding Chart

SAMSARA BIOCAPITAL, LLC NGNE ($21.43) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1